All lobbying filings

RICCHETTI INCORPORATED

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 16, 2025

Income

$20,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
S 339
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Lobbying activity 2

Pharmacy

Issues related to pharmaceutical industry, generally; Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)

Medicare/Medicaid

Issues related to coverage of diagnostic testing for cancer; H.R.842/S.339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.